Distinct folding pathways of two homologous disulfide proteins: Bovine pancreatic trypsin inhibitor and tick anticoagulant peptide

Antioxidants and Redox Signaling

Volumn 14, Issue 1, 2011, Pages 127-135

  Chang, Jui Yoa ^a  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; APROTININ; CYSTINE; DISULFIDE;

CONFORMATIONAL TRANSITION; MOLECULAR MECHANICS; NONHUMAN; OXIDATION; PRIORITY JOURNAL; PROTEIN FOLDING; PROTEIN STRUCTURE; REVIEW;

ANIMALS; ANTICOAGULANTS; APROTININ; CATTLE; DISULFIDES; OXIDATION-REDUCTION; PEPTIDES; PROTEIN FOLDING; TICKS;

BOVINAE; IXODIDA;

EID: 78649475658     PISSN: 15230864     EISSN: None     Source Type: Journal    
DOI: 10.1089/ars.2010.3634     Document Type: Review

References (64)

1. Anfinsen CB. Principles that govern the folding of protein chains. Science 18: 223-230, 1973.
2. Antuch W, Güntert P, Billeter M, Hawthorne T, Grossen-bacher H, and Wüthrich K. NMR solution structure of re-combinant tick anticoagulant protein (rTAP), a factor Xa inhibitor from the tick Ornithodoros moubata. FEBS Lett 352: 251-257, 1994.
3. Arolas JL and Ventura S. Protease inhibitors as models for the study of oxidative folding. Antioxid Redox Signal 14: 97- 112, 2011.
4. Arolas JL, Aviles FX, Chang JY, and Ventura, S. Folding of small disulfide-rich proteins: clarifying the puzzle. Trends Biochem Sci 31: 292-301, 2006.
5. Arolas JL, D'silva L, Popowicz GM, Aviles FX, Holak TA, and Ventura S. NMR structural characterization and computational predictions of the major intermediate in oxidative folding of leech carboxypeptidase inhibitor. Structure 13: 1193-1202, 2005.
6. Arolas JL, Pantoja-Uceda D, Ventura S, Blanco FJ, and Aviles FX. The NMR structures of the major intermediates of the two-domain tick carboxypeptidase inhibitor reveal symmetry in its folding and unfolding pathways. J Biol Chem 283: 27110-27120, 2008.
7. Baldwin RL. How does protein folding get started? Trends Biochem Sci 14: 291-294, 1989.
8. Baldwin RL. The search for folding intermediates and the mechanism of protein folding. Annu Rev Biochem. 37: 1-21, 2008.
9. Cemazar M, Daly NL, Häggblad S, Lo KP, Yulyaningsih E, and Craik DJ. Knots in rings. The circular knotted protein Momordica cochinchinensis trypsin inhibitor-II folds via a stable two-disulfide intermediate. J Biol Chem 281: 8224-8232, 2006.
10. Cemazar M, Joshi A, Daly NL, Mark AE, and Craik DJ. The structure of a two-disulfide intermediate assists in elucidating the oxidative folding pathway of a cyclic cystine knot protein. Structure 16: 842-851, 2008.
11. Cemazar M, Zahariev S, Lopez JJ, Carugo O, Jones JA, Hore PJ, and Pongor S. Oxidative folding intermediates with nonnative disulfide bridges between adjacent cysteine residues. Proc Natl Acad Sci USA 100: 5754-5759, 2003.
12. Chang JY. Controlling the speed of hirudin folding. Biochem J 300: 643-650, 1994.
13. Chang JY. Denatured states of tick anticoagulant peptide. Compositional analysis of unfolded scrambled isomers. J Biol Chem 274: 123-128, 1999.
14. Chang JY. The disulfide folding pathway of tick anticoagulant peptide, a kunitz-type inhibitor structurally homologous to BPTI. Biochemistry 35: 11702-11709, 1996.
15. Chang JY. The folding pathway of alpha-lactalbumin elucidated by the technique of disulfide scrambling. J Biol Chem 277: 120-126, 2002.
16. Chang JY. The property of scrambled hirudins J Biol Chem 270, 25661-25666, 1995.
17. Chang JY and Ballatore A. Structure and heterogeneity of the one- and two-disulfide folding intermediates of tick anticoagulant peptide. J Protein Chem 19: 299-310, 2000.
18. Chang JY and Ballotore A. The structure of denatured bovine pancreatic trypsin inhibitor (BPTI). FEBS Lett 473: 183-187, 2000.
19. Chang JY and Li L. Divergent folding pathways of two homologous proteins, BPTI and tick anticoagulant peptide. Arch Biochem Biophys 437: 85-95, 2005.
20. Chang JY and Li L. Pathway of oxidative folding of a-lact-albumin: a model for illustrating the diversity of disulfide folding pathway. Biochemistry 41: 8405-8413, 2002.
21. Chang JY and Li L. The structure of denatured alpha-lactalbumin elucidated by the technique of disulfide scrambling: fractionation of conformational isomers of alpha-lactalbumin. J Biol Chem 276: 9705-9712, 2001.
22. Chang JY, Li L, and Bulychev A. The underlying mechanism for the diversity of disulfide folding pathway. J Biol Chem 275: 8287-8289, 2000.
23. Chang JY, Li L, and Lai PH. A major kinetic trap for the oxidative folding of human epidermal growth factor. J Biol Chem 276: 4845-4852, 2001.
24. Chang JY, Schindler P, and Chatrenet B. The disulfide structures of scrambled hirudins. J Biol Chem 270: 11992-11997, 1995.
25. Chatrenet B and Chang JY. The disulfide folding pathway of hirudin elucidated by stop=go folding experiments. J Biol Chem 268: 20988-20996, 1993.
26. Craik DJ and Daly NL. Oxidative folding of the cystine knot motif in cyclotide proteins. Protein Pept Lett 12: 147-152, 2005.
27. Creighton TE. Disulfide bonds as probes of protein folding pathways. Methods Enzymol 131: 83-106, 1986.
28. Creighton TE. Protein folding. Biochem J 270: 1-16, 1990.
29. Creighton TE. The disulfide folding pathway of BPTI. Science 256: 111-114, 1992.
30. Daggett V and Fersht AR. Is there a unifying mechanism for protein folding? Trends Biochem Sci 28: 18-25, 2003. (Pubitemid 36051002)
31. Daly NL, Clark RJ, and Craik DJ. Disulfide folding pathways of cystine knot proteins. Tying the knot within the circular backbone of the cyclotides. J Biol Chem 278: 6314-6322, 2003.
32. Dill KA. Dominant forces in protein folding. Biochemistry 29: 7133-7155, 1990.
33. Dill KA, Ozkan SB, Shell MS, and Weikl TR. The protein folding problem. Annu Rev Biochem 37: 289-316, 2008.
34. Dill KA and Shortle D. Denatured states of proteins. Annu Rev Biochem 60:795-825, 1991.
35. Dyson HJ and Wright PE. Insights into protein folding from NMR. Annu Rev Phys Chem 47: 369-395, 1996.
36. Englander SW and Mayne L. Protein folding studied using hydrogen-exchange labeling and two-dimensional NMR. Annu Rev Biophys Biomol Struct 21: 243-265, 1992.
37. Fersht AR. Optimization of rates of protein folding: the nucleation-condensation mechanism and its implications. Proc Natl Acad Sci USA 92: 10869-10873, 1995.
38. Gay GdP, Ruiz-Sanz J, Neira JL, Itzhaki LS, and Fersh AR. Folding of a Nascent Polypeptide Chain in vitro: cooperative formation of structure in a protein module. Proc Natl Acad Sci USA 92: 3683-3686, 1995.
39. Goldenberg DP. Native and non-native intermediates in the BPTI folding pathway. Trends Biochem Sci 17: 257-261, 1992.
40. Kauzmann W. Some factors in the interpretation of protein denaturation. Adv Protein Chem 14: 1-63, 1959.
41. Kim PS and Baldwin RL. Intermediates in the folding reactions of small proteins. Annu Rev Biochem 59: 631-660, 1990.
42. Kim PS and Baldwin RL. Specific intermediates in the folding reactions of small proteins and the mechanism of protein folding. Annu Rev Biochem 51: 459-489, 1982.
43. Laskowski M Jr. and Kato I. Protein inhibitors of proteases. Annu Rev Biochem 49:593-626, 1980.
44. Le-Nguyen D, Heitz A, Chiche L, el Hajji M, and Castro B. Characterization and 2D NMR study of the stable [9-21, 15-27] 2 disulfide intermediate in the folding of the 3 disulfide trypsin inhibitor EETI II. Protein Sci 2: 165-174, 1993.
45. Lim-Wilby MSL, Hallenga K, De Maeyer M, Lasters I, Vlasuk GP, and Brunck TK. NMR structure determination of tick anticoagulant peptide. Protein Sci 4: 178-186, 1995.
46. Mmathambika BS and Bardwell JC. Disulfide-likned protein folding pathway. Annu Rev Cell Dev Biol 24: 211-235, 2008.
47. Narayan M, Welker E, Wedemeyer WJ, and Scheraga HA. Oxidative folding of proteins. Acc Chem Res 33: 805-812, 2000.
48. Pantoja-Uceda D, Arolas JL, Aviles FX, Santoro J, Ventura S, and Sommerhoff CP. Deciphering the structural basis that guides the oxidative folding of leech-derived tryptase inhibitor. J Biol Chem 284: 35612-35620, 2009.
49. Ptitsyn OB. Protein folding: hypotheses and experiments. J Protein Chem 6: 273-293, 1987.
50. Rothwarf D, Li YJ, and Scheraga HA. Regeneration of bovine pancreatic ribonuclease A: identification of two nativelike three-disulfide intermediates involved in separate pathways. Biochemistry 37: 3760-3766, 1998.
51. Salamanca S and Chang JY. Unfolding and refolding pathways of a major kinetic trap in the oxidative folding of alpha-lactalbumin. Biochemistry 44:744-750, 2005.
52. Salamanca S and Chang JY. Pathway of oxidative folding of a 3-disulfide alpha-lactalbumin may resemble either BPTI model or Hirudin model. Protein J 25: 275-287, 2006.
53. Sardana M, Sandana V, Rodkey J, Wood T, Ng A, Vlasuk GP, and Waxman L. Determination of disulfide bond pairs and stability in recombinant tick anticoagulant peptide. J Biol Chem 266: 13560-13563, 1991.
54. Scheraga HA, Wedemeyer WJ, and Welker E. Bovine pancreatic ribonuclease A: oxidative and conformational folding studies. Methods Enzymol 341: 189-221, 2001.
55. Service RF. Problem solved* (*sort of). Science 321: 784-786, 2008.
56. Shortle D. Structural analysis of non-native states of proteins by NMR methods. Curr Opin Struct Biol 6: 24-30, 1996.
57. Shortle D. The expanded denatured state: an ensemble of conformations trapped in a locally encoded topological space. Adv Protein Chem 62: 1-23, 2002.
58. Tanford C. Contribution of hydrophobic interactions to the stability of globular confirmation of proteins. J Am Chem Soc 84: 4240-4247, 1962.
59. Uversky VN and Fink AL. The chicken-egg scenario of protein folding revisited. FEBS Lett 515: 79-83, 2002.
60. Waxman L, Smith DE, Arcuri KE, and Vlasuk GP. Tick anticoagulant peptide (TAP) is a novel inhibitor of blood coagulation factor Xa. Science 248: 593-596, 1990.
61. Weissman JS and Kim PS. Re-examination of the folding of BPTI: predominance of native intermediates. Science 253: 1386-1393, 1991.
62. Welker E, Narayan M, Wedemeyer WJ, and Scheraga HA. Structural determinants of oxidative folding in proteins. Proc Natl Acad Sci 98: 2312-2316, 2001.
63. Wu J, Yang Y, and Watson, JT. Trapping intermediates during the refolding of recombinant human epidermal growth factor (hEGF) by cyanaylation, and subsequent structural elucidation by mass spectrmetry. Protein Sci 7: 1017-1028, 1998.
64. Zhang JX and Goldenberg DP. Amino acid replacement that eliminates kinetic traps in the folding pathway of pancreatic trypsin inhibitor. Biochemistry 32: 14075-14081, 1993.